The Claris Lifesciences IPO GMP strength score is 6.9 out of 10, which the dashboard rates as Good. The Claris Lifesciences IPO QIB category is reserved for 60% of the offer. The Claris Lifesciences IPO NII/HNI category is reserved for 10% of the offer. The Claris Lifesciences IPO Retail (RII) category is reserved for 30% of the offer. Live subscription numbers for the Claris Lifesciences IPO are not yet available, and amounts are calculated at the upper price band of ₹235.
Subscription data for Claris Lifesciences IPO is not available right now. Numbers are updated here during the bidding window.
In Claris Lifesciences IPO, retail investors can apply for a minimum of 1 lot(s) (₹₹5,016); HNI/sNII minimum 40 lots (₹₹200,640); bNII minimum 200 lots (₹₹1,003,200).
Subscription is shares bid for divided by shares offered in that category. If 10 lakh shares are offered and 50 lakh are bid for, the category is subscribed 5 times. Final numbers are confirmed after the bidding closes.
The NII category covers investors applying for shares outside the retail investor category, while HNI commonly refers to high-value investors within the NII category. Understanding the Claris Lifesciences IPO's NII and HNI subscription levels helps investors assess demand for the Claris Lifesciences IPO and overall investor interest.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
